Sharing Value with Shareholders and Enhancing Incentives Through Stock Options
First written in FY2022-Q1. 5 of 6 entries say "Advanced", first in FY2022-Q2. Latest entry: FY2026-H1.
- FY2026-H1AdvancedAnnual report
「Date of resolution 24 December 2025 Categories and number of grantees (people) Executive officers and employees of the Company 11 Number of stock acquisition rights (units)* 402 (Note 1) Class, terms and number of shares underlying the stock acquisition rights (shares)* Common stock 40,200 (Note 1) Exercise price of stock acquisition rights (yen)* 639 Exercise period of stock acquisition rights* From 25 December 2027 to 24 December 2035」
402 stock acquisition rights representing 40,200 shares of common stock were issued to 11 executive officers and employees, with an exercise period from 25 December 2027 to 24 December 2035. - FY2025-H1AdvancedAnnual report
「Date of resolution 20 December 2024 Categories and number of grantees (people) Directors of the Company 1 Executive officers and employees of the Company 12 Number of stock acquisition rights (units)* 500 (Note 1) Class, terms and number of shares underlying the stock acquisition rights (shares)* Common stock 50,000 (Note 1) Exercise price of stock acquisition rights (yen)* 472 (Note 2) Exercise period of stock acquisition rights* From 21 December 2026 to 20 December 2034」
500 stock acquisition rights representing 50,000 shares of common stock were issued to 1 director and 12 executive officers and employees, with an exercise period from 21 December 2026 to 20 December 2034. - FY2024-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows: 1 director, 8 executive officers and employees; 410 stock acquisition rights; 41,000 shares of common stock; an exercise price of ¥630; and an exercise period from 23 December 2025 to 22 December 2033.」
410 stock acquisition rights representing 41,000 shares of common stock were issued to 1 director and 8 executive officers and employees in connection with the ninth issuance, with an exercise period from 23 December 2025 to 22 December 2033. - FY2022AdvancedAnnual report
「Eighth Series Stock Acquisition Rights Common shares 65,300」
Regarding the Eighth Series Stock Acquisition Rights, 65,300 shares remained outstanding after deducting lapsed shares from the initial grant of 67,600 shares. - FY2022-Q2AdvancedAnnual report
「The Stock Acquisition Rights issued under the Companies Act during the second-quarter accounting period are as follows: Eighth Series Stock Acquisition Rights」
The issuance of the Eighth Series Stock Acquisition Rights was completed, with the grant of 676 units, equivalent to 67,600 common shares, to 3 directors, executive officers and 56 employees finalized. - FY2022-Q1First statedAnnual report
「The company will issue these Stock Acquisition Rights to its directors, excluding outside directors, executive officers and employees, with the aim of sharing more fully with shareholders the benefits and risks of share price movements and increasing their motivation and morale to improve the company's performance and corporate value.」
The company resolved to issue the Eighth Series Stock Acquisition Rights and established a plan to grant 67,600 shares to 3 directors, executive officers and 56 employees. The exercise period is from 15 May 2024 to 15 December 2031.